Chiara Mascoli, Gianluca Faggioli, Enrico Gallitto, Vincenzo Vento, Giuseppe Indelicato, Rodolfo Pini, Andrea Vacirca, Andrea Stella, Mauro Gargiulo
Journal: Contrast media & molecular imaging 2019;2018():7647165
PMID: 29780288
INTRODUCTION
Iodinated contrast media completion angiography (ICM-A) may underestimate the presence of type II endoleak (ELII) after endovascular aortic repair (EVAR), particularly if they are at low flow. Contrast-enhanced ultrasound (CEUS) has been proposed as the gold standard in ELII detection during EVAR follow-up. Intraprocedural carbon dioxide (CO) angiography has been shown to be useful in this setting; however no comparative studies including these three techniques are currently available. Our aim was to investigate the accuracy of a new automated CO angiographic (CO-A) system in the detection of ELII, by comparing it with ICM-A and CEUS.
METHODS
A series of consecutive patients undergoing EVAR for abdominal aortic aneurysm (AAA) were enrolled and submitted to ICM-A and CO-A during the procedure. The iodinated contrast media were delivered through an automatic injector connected to a pigtail catheter in the suprarenal aorta. CO was delivered through a recently available automatic injector connected to a 10 F sheath positioned in the external iliac artery. All patients were blindly evaluated by CEUS within postoperative day 1. The ICM-A and CO-A ability to detect ELII was compared with that of CEUS through Cohen's concordance Index ().
RESULTS
Twenty-one patients were enrolled in the study. One (5%), seven (33%), and four (19%) ELII were detected by ICM-A, CO-A, and CEUS, respectively. The only ELII detected by ICM-A was also detected by CO-A and CEUS. Three cases of ELII detected by CO-A were not detected by CEUS. All ELII detected by CEUS were visualized by CO-A. CEUS and ICM-A showed a poor agreement (Cohen's : 0.35) while CEUS and CO-A showed a substantial agreement (Cohen's : 0.65) for ELII detection.
CONCLUSION
CO-A is safe and effective method for ELII detection in EVAR, with a significantly higher agreement with CEUS if compared with ICM-A. This trial is registered with 155/2015/U/Oss.
Full Text Sources:
Medical:
Other Literature Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.